|
Volumn 10, Issue 3, 2000, Pages 150-155
|
When and where to start: Guidelines for the initiation of antiretroviral therapy
|
Author keywords
Adherence; Antiretroviral combinations; First line therapy; Non nucleoside reverse transcriptase inhibitors; Nucleoside analogues; Protease inhibitors; Treatment guidelines
|
Indexed keywords
ABACAVIR;
ANTIRETROVIRUS AGENT;
DIDANOSINE;
INDINAVIR;
LAMIVUDINE;
NEVIRAPINE;
NUCLEOSIDE ANALOG;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
STAVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CONFERENCE PAPER;
HUMAN;
IMMUNOCOMPETENCE;
LYMPHOCYTE COUNT;
OPPORTUNISTIC INFECTION;
PRACTICE GUIDELINE;
TREATMENT INDICATION;
TREATMENT PLANNING;
VIRUS LOAD;
ADULT;
ANTI-HIV AGENTS;
CD4 LYMPHOCYTE COUNT;
DRUG THERAPY, COMBINATION;
HUMANS;
NUCLEOSIDES;
PATIENT COMPLIANCE;
PRACTICE GUIDELINES;
PROTEASE INHIBITORS;
RETROVIRIDAE;
RETROVIRIDAE INFECTIONS;
REVERSE TRANSCRIPTASE INHIBITORS;
TREATMENT FAILURE;
VIRAL LOAD;
|
EID: 0034061365
PISSN: 10530894
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (8)
|
References (11)
|